Buscar
Mostrando ítems 1-10 de 155
Therapeutic Drug Monitoring of Vancomycin
(2009)
Vancomycin, a glycopeptide antibiotic, was developed and released in the 1950's for the treatment of aerobic gram-positive infections and has been widely used mainly in the treatment of methicillin-resistant Staphylococcus ...
Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit Monitoreo terapéutico de vancomicina intravenosa en una unidad de paciente crítico pediátrico
(Sociedad Chilena de Infectologia, 2014)
Background: In critically ill pediatric patients vancomycin distribution and elimination is altered underscoring the need for pharmacokinetic monitoring; however the therapeutic trough ranges have not been validated for ...
Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer
(Lippincott Williams & Wilkins, 2016)
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pediatric oncology patients, we analyzed 256 measurements of vancomycin concentrations in 94 patients. Variables were tested ...
Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients: A Prospective Cohort Clinical Study
(2019-01-01)
Introduction: Vancomycin pharmacokinetic data in patients with acute kidney injury (AKI) on high-volume peritoneal dialysis (HVPD) are lacking. The aims were to study the pharmacokinetics of i.v. vancomycin in patients ...
Resistance to last resort antibiotics in gram-positive cocci: the post-vancomycin era
(Instituto Nacional de Salud de Colombia, 2014)
New therapeutic alternatives have been developed in the last years for the treatment of multidrug-resistant Gram-positive infections. Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant ...
Resistance to last resort antibiotics in gram-positive cocci: the post-vancomycin era
(Instituto Nacional de Salud de Colombia, 2014)
New therapeutic alternatives have been developed in the last years for the treatment of multidrug-resistant Gram-positive infections. Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant ...
Serum concentration of vancomycin is a diagnostic predictor of nephrotoxic acute kidney injury in septic patients in clinical and surgical wards
(2020-01-01)
Introduction and Aim: There have been few studies to evaluate the monitoring of plasmatic concentrations of vancomycin in septic patients and their association with acute kidney injury (AKI) and death. This study aimed to ...
The use of vancomycin with its therapeutic and adverse effects: a review
(Verduci Publisher, 2015-01-01)
OBJECTIVE: Vancomycin (VCM) is a tricyclic glycopeptide antibiotic produced by Streptococcus orientalis. Widely used in hospitals, it is indicated to fight severe infections caused by Gram-positive bacteria, especially ...